Industry

DUBLIN–(BUSINESS WIRE)–The “Dupilumab Emerging Drug Insight and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about Dupilumab for Food Allergy in the 7MM. A detailed picture of the Dupilumab for Food Allergy in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), … [Read more…]

NEW YORK–(BUSINESS WIRE)–Edgemont Partners (“Edgemont”), a premier healthcare-dedicated investment bank and leading M&A and capital raising advisor, is pleased to announce that Sarah Pringle has joined the firm as Director to lead and expand its financial sponsor coverage. David Blume and Jeff Swearingen, Co-founders and Managing Directors of Edgemont, stated: “We are excited for Sarah … [Read more…]

– Patient-derived biomarker and preclinical data demonstrate significant opportunity to address immune-excluded tumors, such as colorectal, NSCLC, ovarian, pancreas, and TNBC – First in human clinical trial of lead asset, PRTH-101, expected to initiate 3Q23 BOSTON–(BUSINESS WIRE)–Parthenon Therapeutics, a precision oncology company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME), … [Read more…]

Chegg launches partnership with Calm, which will give students hundreds of hours of content in seven languages to help them focus, manage their stress, and practice mindfulness. SANTA CLARA, Calif.–(BUSINESS WIRE)–Chegg, Inc. (NYSE: CHGG), the leading student-first online learning company, today announced a global partnership with Calm, in which Chegg Study Pack users will gain … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Immuno-oncology Clinical Trials Market Research Report by Design, Phase, Indication, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Immuno-oncology Clinical Trials Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Choroideremia – Pipeline Insight, 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Choroideremia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, … [Read more…]

BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Trimethoprim Tablets USP, 100 mg. ANI’s Trimethoprim Tablets are the generic version of the Reference Listed Drug (RLD) of the same established name. The … [Read more…]

IRVING,Texas–(BUSINESS WIRE)–Sg2, a Vizient company, announces the launch of Provider Connections, an analytics solution to help healthcare organizations improve patient care coordination through greater physician engagement and network optimization. Every year physician referrals made outside of network can cost healthcare organizations hundreds of millions of dollars. Sg2 Provider Connections takes direct aim at network leakage … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Cluster Headache Syndrome – Pipeline Insight, 2022” report has been added to ResearchAndMarkets.com’s offering. This “Cluster Headache Syndrome- Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Cluster Headache Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Home Infusion Therapy Market By Indication Analysis, By Product Analysis & By Region-Forecast and Analysis 2022-2028” report has been added to ResearchAndMarkets.com’s offering. Global home infusion therapy market size was valued at USD 34.54 billion in 2021, and it is expected to reach a value of USD 54.82 billion by 2028, at … [Read more…]